01—Abstract
Summary
Summary of the 8-K filed November 6, 2024. Cited figures are marked; the original filing is the authoritative source.
Corteva's 8-K furnishes its third-quarter 2024 results, which were weak.
Net sales fell 10% year over year to $2.33 billiona (down 5% organically), driven by Latin America, where Seed volumes dropped on reduced corn planted area in Argentina and Crop Protection pricing came under pressure. GAAP loss from continuing operations was $519 million ($0.76 per share), and Operating EBITDA was a loss of $100 million versus a gain of $18 million a year earlier. Operating EPS was a loss of $0.49.
Year to date, net sales were $12.93 billionb (down 4%), GAAP EPS from continuing operations was $1.29, and Operating EPS was $2.24. Seed Operating EBITDA was still up 8% year to date, while Crop Protection Operating EBITDA fell 27%. Management cut full-year 2024 guidance.
Net sales are now expected at $17.0 to $17.2 billionc, Operating EBITDA at $3.35 to $3.45 billion, and Operating EPS at $2.50 to $2.60, which is about 5% lower at the midpoint. Free cash flow guidance is $1.5 to $2.0 billion, and the company expects to have repurchased about $1 billion of stock in 2024. The company also gave a preliminary 2025 outlook of $17.3 to $17.7 billion in net sales and $3.6 to $4.0 billion in Operating EBITDA, implying roughly 12% Operating EBITDA growth at the midpoint.
Item 2.05 discloses an expanded Crop Protection Operations Strategy Restructuring Program, centered on exiting production at the Pittsburg, California site and ceasing operations on select manufacturing lines elsewhere. Total pre-tax restructuring and asset-related charges are now estimated at $650 to $700 milliond, with $330 to $360 million of cash payments, and the program should be substantially complete by the end of 2026.
The Item 2.05 text is dated November 8, 2023, which appears to be a typographical error for 2024. Investors should watch the Investor Day on November 19, 2024 for updated strategy and multi-year financial targets through 2027.
02—Key points
Key Highlights
- Q3 2024 net sales were $2.33 billion, down 10% (down 5% organic), with Latin America down 19% and Seed sales down 21%.
- Q3 GAAP loss from continuing operations was $519 million ($0.76 per share), and Operating EBITDA swung to a $100 million loss from an $18 million gain a year earlier.
- Seed Operating EBITDA fell to a $320 million loss in Q3, driven by Latin America volume declines and higher commodity and cost of sales, while Crop Protection Operating EBITDA rose 34% to $246 million.
- FY2024 guidance was lowered: net sales of $17.0 to $17.2 billion, Operating EBITDA of $3.35 to $3.45 billion, and Operating EPS of $2.50 to $2.60.
- Preliminary 2025 outlook calls for net sales of $17.3 to $17.7 billion and Operating EBITDA of $3.6 to $4.0 billion, signaling margin recovery.
- The expanded Crop Protection restructuring program carries $650 to $700 million in pre-tax charges and $330 to $360 million in cash costs, with completion targeted by end-2026.
- Year-to-date Operating EBITDA was $2.85 billion (down 5%), and the company still expects about $1 billion of 2024 share repurchases and $1.5 to $2.0 billion of free cash flow.
03—Questions
Frequently Asked Questions
Why did Corteva post a loss in Q3 2024 when it was profitable in the first half?
The Q3 loss reflects a seasonal sales trough combined with specific pressures: Seed volumes fell 12% on lower Argentina corn acreage, Seed price fell 5% on end-of-season settlements in North America, Crop Protection pricing fell 10% on competition in Latin America, and currency and restructuring charges added to the decline. GAAP results also include $33 million of significant items in the quarter. Management's Operating EBITDA loss of $100 million was well below the prior-year Q3 result of $18 million.
Why did management lower full-year 2024 guidance?
Net sales guidance was lowered to $17.0 to $17.2 billion, and Operating EPS guidance to $2.50 to $2.60, reflecting weaker Latin America market conditions, including a significant reduction in Argentine corn planted area, and a competitive Crop Protection pricing environment. Management noted that Seed continued to outperform the market and that Crop Protection showed resilience from productivity gains and raw material deflation.
What is the restructuring program, and what will it cost investors?
The Crop Protection Operations Strategy Restructuring Program optimizes the company's manufacturing and external partner network, including exiting production in Pittsburg, California and ceasing operations on select lines elsewhere. Pre-tax charges are now estimated at $650 to $700 million, including $85 to $105 million of severance, $320 to $340 million of asset-related and impairment charges, and $245 to $255 million for exit costs. Cash payments are expected to total $330 to $360 million, mainly for decommissioning, contract terminations, and severance. The filing notes that site disposition gains or losses could change these estimates.
Is the 2025 outlook a sign of recovery, and what should investors monitor?
The preliminary 2025 outlook implies about 2% net sales growth and about 12% Operating EBITDA growth at the midpoint, indicating expected margin expansion as pricing, productivity, and restructuring benefits build. Investors should monitor Latin America demand and pricing, Crop Protection competitive pricing, the pace of restructuring savings, and the Investor Day on November 19, 2024, where management is expected to provide financial targets through 2027. The outlook is preliminary, and the company does not provide GAAP reconciliations for its forward-looking non-GAAP measures.
04—Continue